Streetbeat News

Revenues

CCOEY

EA

MSFT

OTGLY

WBD

Valve's Steam has released its 'Best of 2023' list, featuring the top-selling and most-played games of the year. The list includes games from Electronic Arts Inc (EA), Microsoft Corp (MSFT), Warner Bros. Discovery Inc (WBD), CD Projekt ADR (OTGLY), and Capcom ADR (CCOEY). The rankings are based on sales revenue and concurrent player numbers from January 1 to December 15, 2023. New releases like Street Fighter 6 and Baldur's Gate 3 were among the high revenue generators, while Steam Deck highlighted Elden Ring and Cyberpunk 2077.

Portfolio Pulse from Franca Quarneti

December 29, 2023 | 4:19 pm

COST

The analysis of Costco Wholesale (NASDAQ:COST) in the Consumer Staples Distribution & Retail industry reveals a high PE, PB, and PS ratio compared to industry averages, suggesting a premium stock valuation. Costco's ROE and EBITDA are above average, indicating profitability and efficiency. However, lower gross profit and revenue growth could signal challenges ahead. The company's low debt-to-equity ratio suggests a strong financial position with less reliance on debt.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 4:00 pm

GSK

PFE

SNY

TAK

Major pharmaceutical companies including Pfizer, Sanofi, and Takeda Pharmaceutical are planning to raise prices on over 500 drugs in the U.S. in early January, ahead of the Biden Administration's publication of discounted prices for ten high-cost drugs in September. This move is in response to inflation and increased manufacturing costs. Meanwhile, GSK is set to lower prices on at least 15 drugs in January, following price reductions on specific drugs for 2024. Drug price increases have been kept under 10% since 2019, reflecting a cautious approach by drugmakers.

Portfolio Pulse from Vandana Singh

December 29, 2023 | 3:31 pm

PFE

SNY

TAK

Pfizer, Sanofi, and Takeda are set to increase prices on over 500 unique drugs in the US in early January, according to data from 3 Axis Advisors reported by Reuters.

Portfolio Pulse from Charles Gross

December 29, 2023 | 2:17 pm

AMTD

HKD

AMTD's film 'The Goldfinger' is set for a global release tomorrow. This could potentially increase visibility and revenue for AMTD, impacting its stock positively in the short term.

Portfolio Pulse from Bill Haddad

December 29, 2023 | 2:17 pm

WLGS

Wang & Lee Group, Inc. reported a 15.2% increase in sales for the first half of the year, with total sales reaching $1.44 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 2:03 pm

BGC

BGC Group anticipates Q4 revenue to be near the upper range of its forecasted $450M-$500M, with consensus at $475M. The company also expects double-digit growth in revenue and pre-tax adjusted earnings for both Q4 and the full year of 2023.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 1:12 pm

BFRG

Bullfrog AI Holdings' CEO released a letter to shareholders discussing the progress of their drug candidate, BF-114, for liver disease and obesity. The CEO highlighted a pre-clinical animal study and pointed out the potential of the obesity drug market, which is projected to surpass $77 billion by 2030.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 1:05 pm

DTCK

Davis Commodities Ltd reported financial results for the first half of FY23 with revenue of $97.8M, down from $100.7M last year. Gross profit decreased to $4.2M from $6.7M, while income from operations and net income saw significant increases to $2.2M and $2.0M, respectively. EPS rose to $0.08 from $0.05.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 1:04 pm

SSKN

Strata Skin Sciences (SSKN) has announced the expansion of its distribution agreement with Kosmo Meditech, aiming to enhance the distribution of its products. This strategic move is expected to increase market penetration and revenue growth for Strata Skin Sciences.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 1:01 pm